SYK and asthma: In particular, STAT6 regulates the T helper type 2 (Th2) immune response, PAI-1 is associated with asthma severity because of its role in airway remodeling, while Syk is implicated as central immune modulator promoting allergic airway inflammation; thus, their inhibition could be an effective therapeutic approach in asthma.